Even if the ultra-rich are able to extend human lifespan, would it be ethical?
Scroll India ,
Sam Altman, the chief executive of OpenAI, recently invested $180 million into Retro Biosciences – a company seeking to extend…
Sam Altman, the chief executive of OpenAI, recently invested $180 million into Retro Biosciences – a company seeking to extend…
Sam Altman, the chief executive of OpenAI, recently invested US$180 million into Retro Biosciences—a company seeking to extend…
Altman isn’t the only Silicon Valley entrepreneur supporting life extension efforts.
Altman isn’t the only Silicon Valley entrepreneur supporting life extension efforts.